Patrick Lin - Feb 17, 2025 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Business - Strategy Off
Signature
/s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Feb 17, 2025
Transactions value $
$0
Form type
4/A - Amendment
Date filed
2/18/2025, 05:54 PM
Date Of Original Report
Jan 29, 2025
Previous filing
Jan 29, 2025
Next filing
Apr 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PCSA Common Stock 29.1K Feb 17, 2025 Direct
holding PCSA Common Stock 43.5K Feb 17, 2025 Lin Family Trust Feb 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Warrants Award $0 +43.5K $0.00 43.5K Jan 29, 2025 Common Stock 43.5K $0.65 Lin Family Trust Feb 4, 2024
transaction PCSA Warrants Award $0 +21.8K $0.00 21.8K Jan 29, 2025 Common Stock 21.8K $0.65 Lin Family Trust Feb 4, 2024
* An asterisk sign (*) next to the price indicates that the price is likely invalid.